Evaluation of Efficacy and Safety of SDN-037

Inclusion Criteria:

1. Be at least 2 years of age on the date of assent or 18 years of age at the date of
consent

2. Be able and willing to follow study instructions and complete all required visits

3. Females of childbearing potential must not be pregnant (as confirmed by a negative
urine pregnancy test

4. Able to self-instill the IP or have a caregiver available to instil all doses of the
IP

Exclusion Criteria:

1. Any known allergy or hypersensitivity to difluprednate therapy

2. An acute ocular infection (bacterial, viral or fungal) or active ocular inflammation
in the study eye

3. Any active corneal pathology noted in the study eye

4. Currently suffering from alcohol and/or drug abuse